193 related articles for article (PubMed ID: 1982272)
1. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
White FJ; Hu XT; Brooderson RJ
Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
[No Abstract] [Full Text] [Related]
2. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
Subramaniam S; Lucki I; McGonigle P
Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
[TBL] [Abstract][Full Text] [Related]
3. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
4. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
Asin KE; Bednarz LM
Neurosci Lett; 1990 Jun; 113(3):286-91. PubMed ID: 2143274
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.
Eilam D; Clements KV; Szechtman H
Behav Brain Res; 1991 Nov; 45(2):117-24. PubMed ID: 1686397
[TBL] [Abstract][Full Text] [Related]
6. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
Delfs JM; Kelley AE
Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
8. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
Braun AR; Barone P; Chase TN
Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
[No Abstract] [Full Text] [Related]
9. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
Jiang LH; Kasser RJ; Altar CA; Wang RY
J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
[TBL] [Abstract][Full Text] [Related]
10. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
[TBL] [Abstract][Full Text] [Related]
11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
13. MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease.
Morelli M; Di Chiara G
Eur J Pharmacol; 1990 Jul; 182(3):611-2. PubMed ID: 1977595
[No Abstract] [Full Text] [Related]
14. Rotation in response to selective dopamine receptor agonists in rats with electrolytic substantia nigra lesions.
Asin KE; Bednarz L; Montana W
Life Sci; 1990; 46(25):1817-23. PubMed ID: 1972973
[TBL] [Abstract][Full Text] [Related]
15. Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.
Morelli M; Fenu S; Cozzolino A; Pinna A; Carta A; Di Chiara G
Neuroscience; 1993 Apr; 53(3):673-8. PubMed ID: 8098138
[TBL] [Abstract][Full Text] [Related]
16. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
Shen RY; Asdourian D; Chiodo LA
Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398
[TBL] [Abstract][Full Text] [Related]
17. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
Arnt J; Hyttel J; Perregaard J
Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
Maslowski RJ; Napier TC
Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
